BRPI0415557A - formulação contendo ingrediente ativo farmacêutico com revestimento - Google Patents

formulação contendo ingrediente ativo farmacêutico com revestimento

Info

Publication number
BRPI0415557A
BRPI0415557A BRPI0415557-2A BRPI0415557A BRPI0415557A BR PI0415557 A BRPI0415557 A BR PI0415557A BR PI0415557 A BRPI0415557 A BR PI0415557A BR PI0415557 A BRPI0415557 A BR PI0415557A
Authority
BR
Brazil
Prior art keywords
active pharmaceutical
formulation containing
pharmaceutical ingredient
coated active
containing coated
Prior art date
Application number
BRPI0415557-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Karin Klokkers
Marion Zellner
Thomas Rillmann
Andreas Dauer
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34553325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0415557(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2003151301 external-priority patent/DE10351301A1/de
Priority claimed from DE200410014828 external-priority patent/DE102004014828A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of BRPI0415557A publication Critical patent/BRPI0415557A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0415557-2A 2003-10-31 2004-10-28 formulação contendo ingrediente ativo farmacêutico com revestimento BRPI0415557A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2003151301 DE10351301A1 (de) 2003-10-31 2003-10-31 Retardierte Dosisform aus mehreren Einzeleinheiten
DE200410014828 DE102004014828A1 (de) 2004-03-24 2004-03-24 Pharmazeutische wirkstoffhaltige Formulierung mit Überzug
PCT/EP2004/012230 WO2005041934A2 (de) 2003-10-31 2004-10-28 Pharmazeutische wirkstoffhaltige formulierung mit überzug

Publications (1)

Publication Number Publication Date
BRPI0415557A true BRPI0415557A (pt) 2006-12-26

Family

ID=34553325

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415557-2A BRPI0415557A (pt) 2003-10-31 2004-10-28 formulação contendo ingrediente ativo farmacêutico com revestimento

Country Status (12)

Country Link
US (1) US20080254112A1 (cg-RX-API-DMAC7.html)
EP (1) EP1677766B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007509891A (cg-RX-API-DMAC7.html)
AT (1) ATE549015T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004285284B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0415557A (cg-RX-API-DMAC7.html)
CA (1) CA2543689A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06004700A (cg-RX-API-DMAC7.html)
NO (1) NO20062051L (cg-RX-API-DMAC7.html)
NZ (1) NZ547284A (cg-RX-API-DMAC7.html)
RU (1) RU2372893C2 (cg-RX-API-DMAC7.html)
WO (1) WO2005041934A2 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
CA2642340A1 (en) * 2006-02-24 2007-08-30 Teva Pharmaceutical Industries Ltd. Metoprolol succinate e.r. tablets and methods for their preparation
LT3103448T (lt) * 2006-09-26 2019-10-10 Novartis Ag Farmacinės kompozicijos, apimančios s1p moduliatorių
US8367115B2 (en) 2007-08-27 2013-02-05 Asahi Kasei Chemicals Corporation Process for production of crystalline cellulose and tablets containing granules
JP5204846B2 (ja) * 2007-09-21 2013-06-05 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング エタノールの影響に対して耐性を有する非オピオイド薬のｐＨ依存性制御放出医薬組成物
CA2699227C (en) * 2007-09-21 2014-12-02 Evonik Roehm Gmbh Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
EP2231122A1 (en) * 2008-01-10 2010-09-29 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
MX2010007579A (es) * 2008-01-10 2010-08-03 Evonik Roehm Gmbh Preparacion nutriceutica o farmaceutica revestida con una liberacion de sustancia activa de impulsion mejorada.
RU2011102777A (ru) * 2008-06-26 2012-08-10 МакНЕЙЛ-ППС, ИНК. (US) Частицы с покрытием, содержащие фармацевтически активные агенты
WO2010026993A1 (ja) 2008-09-03 2010-03-11 武田薬品工業株式会社 製剤における吸収性改善方法および吸収性が改善された製剤
US20110311631A1 (en) * 2009-03-18 2011-12-22 Evonik Röhm Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
KR101571198B1 (ko) * 2009-03-18 2015-11-23 에보니크 룀 게엠베하 중성 비닐 중합체 및 부형제를 포함하는 코팅을 이용하는, 에탄올의 영향에 대한 내성을 갖는 제어 방출 제약 조성물
US8388983B2 (en) * 2009-05-12 2013-03-05 Bpsi Holdings, Llc Film coatings containing fine particle size detackifiers and substrates coated therewith
US8647645B2 (en) * 2009-05-12 2014-02-11 Bpsi Holdings, Llc Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
WO2011136373A1 (ja) 2010-04-30 2011-11-03 武田薬品工業株式会社 腸溶性錠剤
US20130115292A1 (en) 2010-04-30 2013-05-09 Takeda Pharmaceutical Company Limited Enteric tablet
FR2968559B1 (fr) * 2010-12-14 2012-12-28 Alexandra Fregonese Nouvelles compositions a base d'argile et de beepollen, leur procede de preparation et leurs utilisations en nutrition et en therapeutique
ES2583132T3 (es) * 2011-09-16 2016-09-19 Purdue Pharma L.P. Formulaciones de liberación inmediata resistentes a alteración
US20140341984A1 (en) * 2011-09-16 2014-11-20 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11638759B2 (en) 2019-08-13 2023-05-02 Darlene E. McCord Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
JP7482645B2 (ja) * 2020-02-18 2024-05-14 沢井製薬株式会社 核粒子を含む顆粒の製造方法
US12213993B2 (en) 2021-10-25 2025-02-04 Darlene E. McCord Coated medicinal clay compositions, pharmaceutical compositions, and delivery of cation sources and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
DE3900811A1 (de) * 1989-01-13 1990-07-19 Kali Chemie Pharma Gmbh Neue arzneiform
CH687810A5 (de) * 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
CA2177769C (en) * 1995-06-07 1999-08-24 Gyanesh P. Khare Particulate compositions that comprise zinc aluminate
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
EA002806B1 (ru) * 1997-09-11 2002-10-31 Нюкомед Данмарк А/С Многоединичные композиции с модифицированным высвобождением нестероидных противовоспалительных лекарственных веществ (nsaid)
US6328994B1 (en) * 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
DE19905906A1 (de) * 1999-02-11 2000-08-17 Basf Ag Verwendung von wasserlöslichen oder wasserdispergierbaren Polyether-haltigen Polymerisaten als Überzugsmittel, Bindemittel und/oder filmbildender Hilfsstoff in pharmazeutischen Darreichungsformen
DE19850238A1 (de) * 1998-10-31 2000-05-04 Triple Trian Beteiligungs Gmbh Verfahren und Vorrichtung zur Kompensation von Elektrosmog
EA200201044A1 (ru) * 2000-03-31 2003-04-24 Нюкомед Аустриа Гмбх Фармацевтическая композиция с контролируемым высвобождением, содержащая мидодрин и/или десглимидодрин
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
SE0100200D0 (sv) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
DE10149674A1 (de) * 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
RU2323717C2 (ru) * 2001-12-19 2008-05-10 Астразенека Аб Новое пленочное покрытие
EP1651192A1 (en) * 2003-08-06 2006-05-03 Nirmal Mulye Pharmaceutical composition containing water soluble drug

Also Published As

Publication number Publication date
AU2004285284A1 (en) 2005-05-12
EP1677766A2 (de) 2006-07-12
AU2004285284B2 (en) 2010-03-25
ATE549015T1 (de) 2012-03-15
NZ547284A (en) 2009-12-24
RU2006118689A (ru) 2007-12-20
WO2005041934A3 (de) 2005-12-01
JP2007509891A (ja) 2007-04-19
MXPA06004700A (es) 2006-07-05
EP1677766B1 (de) 2012-03-14
US20080254112A1 (en) 2008-10-16
CA2543689A1 (en) 2005-05-12
NO20062051L (no) 2006-07-25
WO2005041934A2 (de) 2005-05-12
RU2372893C2 (ru) 2009-11-20

Similar Documents

Publication Publication Date Title
BRPI0415557A (pt) formulação contendo ingrediente ativo farmacêutico com revestimento
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
EP1354590A4 (en) MEDICINES AGAINST JOINT DEFECTS
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
HUP0401714A2 (hu) Propiverin vagy gyógyászatilag elfogadható sóinak nyújtott hatóanyag-eladású, orális adagolási formái
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
MXPA03008756A (es) Derivados de n-(arilsulfonil) beta-aminoacidos que comprenden un grupo aminometilo substituido, el metodo de preparacion de los mismos y las composiciones farmaceuticas que los contienen.
BRPI0615860B8 (pt) composição farmacêutica de liberação prolongada monolítica sólida
BR0314182A (pt) Formulações compreendendo um composto de indolinona
CY1119188T1 (el) Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας
NO20062019L (no) P-glykoproteininhibitor, fremgangsmater for fremstilling av denne samt farmasoytiske preparater inneholdende den samme
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2005117895A8 (en) Compositions comprising meloxicam
BR0317452A (pt) Métodos para revestimento de substratos para usos farmacêuticos com uma mistura de dois agentes de revestimento formadores de pelìculas
WO2005004915A3 (en) Compositions comprising meloxicam
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
WO2004069187A3 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
GEP20043377B (en) Pharmaceutical Complex
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
HRP20090102T3 (hr) Poboljšana farmaceutska smjesa koja sadrži ace inhibitor i postupak za njeno pripravljanje

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI.A61K 9/16, A61K 9/36, A61P 25/04

Ipc: A61K 9/16 (2011.01), A61K 9/36 (2011.01), A61P 25/

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]